Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 30:2021:8610285.
doi: 10.1155/2021/8610285. eCollection 2021.

Cognitive Impairment in Genetic Parkinson's Disease

A Planas-Ballvé  1 , D Vilas  2
Affiliations
Review

Cognitive Impairment in Genetic Parkinson's Disease

A Planas-Ballvé et al. Parkinsons Dis. .

Abstract

Cognitive impairment is common in idiopathic Parkinson's disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment is higher in GBA- and SNCA-associated PD, lower in Parkin- and PINK1-PD, and possibly milder in LRRK2-PD. In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this study.

References

    1. Lawson R. A., Yarnall A. J., Duncan G. W. Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease. Journal of Neurology Neurosurgery and Psychiatry . 2017;88:648–652. doi: 10.1136/jnnp-2016-315099. - DOI - PMC - PubMed
    1. Santangelo G., Vitale C., Picillo M. Mild cognitive impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism & Related Disorders . 2015;21(10):1219–1226. doi: 10.1016/j.parkreldis.2015.08.024. - DOI - PubMed
    1. Aarsland D., Andersen K., Larsen J. P. Prevalence and characteristics of dementia in Parkinson disease: an 8 year prospective study. Archives of Neurology . 2003;60(3):387–397. doi: 10.1001/archneur.60.3.387. - DOI - PubMed
    1. Hely M. A., Reid W. G., Adena M. A. The Sidney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Movement Disorders . 2008;23(6):837–844. doi: 10.1002/mds.21956. - DOI - PubMed
    1. Aarsland D., Bronnick K., Williams-Gray C. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology . 2010;75(12):1062–1069. doi: 10.1212/wnl.0b013e3181f39d0e. - DOI - PMC - PubMed

LinkOut - more resources